The rapid development of single-cell RNA-sequencing (scRNA-seq) technology, with increased sparsity compared to bulk RNA-sequencing (RNA-seq), has led to the emergence of many methods for preprocessing, including imputation methods. Here, we systematically evaluate the performance of 18 state-of-the-art scRNA-seq imputation methods using cell line and tissue data measured across experimental protocols. Specifically, we assess the similarity of imputed cell profiles to bulk samples as well as investigate whether methods recover relevant biological signals or introduce spurious noise in three downstream analyses: differential expression, unsupervised clustering, and inferring pseudotemporal trajectories. Broadly, we found significant variability in the performance of the methods across evaluation settings. While most scRNA-seq imputation methods recover biological expression observed in bulk RNA-seq data, the majority of the methods do not improve performance in downstream analyses compared to no imputation, in particular for clustering and trajectory analysis, and thus should be used with caution. Furthermore, we find that the performance of scRNA-seq imputation methods depends on many factors including the experimental protocol, the sparsity of the data, the number of cells in the dataset, and the magnitude of the effect sizes. We summarize our results and provide a key set of recommendations for users and investigators to navigate the current space of scRNA-seq imputation methods. 7 Figure 1 . Motivation and overview of benchmark evaluation of scRNA-seq imputation methods. (A) Dimension reduction results after applying Principal Components Analysis (PCA) from either no imputation method (no_imp highlighted in red) or the 18 imputation methods using the null simulations data (Section 5.3) in which no structural pattern is expected. The color represents the simulated library size (defined as the total sum of counts across all relevant features) for each cell. (B) An overview of the benchmark comparison evaluating 18 scRNA-seq imputation methods.
Introduction 9
Recent advances in high-throughput technologies have been developed to measure gene expression in individual cells [1] [2] [3] [4] [5] . 10 In contrast to bulk RNA-sequencing (RNA-seq), a distinctive feature of data measured using single-cell RNA-sequencing 11 (scRNA-seq) is the increased sparsity, or fraction of observed 'zeros', where a zero refers to no unique molecular identifiers 12 (UMIs) or reads mapping to a given gene in a cell [6] [7] [8] [9] . These observed zeros can be due to biological (relevant or nuisance) 13 fluctuations in the measured trait or technical limitations related to challenges in quantifying small numbers of molecules. 14 Examples of the latter include mRNA degradation during cell lysis or variation by chance of sampling lowly expressed 15 transcripts 10 . The word dropout 6-8 has been previously used to describe both biological and technical observed zeros, but the 16 problem with using this catch-all term is it does not distinguish between the types of sparsity 10 . 17 To address the increased sparsity observed in scRNA-seq data, recent work has led to the development of "imputation" 18 methods, in a similar spirit to imputing genotype data for genotypes that are missing or not observed. However, one major 19 difference is that in scRNA-seq standard transcriptome reference maps, such as the Human Cell Atlas 11 or the Tabula Muris 20 Consortium 12 are not yet widely available for all species, tissue types, genders, and so on. Therefore, the majority of imputation 21 methods developed to date do not rely on an external reference map. They can also be categorized into three broad approaches 10 . 22 The first group are imputation methods that directly model the sparsity using probabilistic models. These methods may or may 23 not distinguish between biological and technical zeros, but if they do, they typically impute gene expression values for only the 24 latter. A second approach adjusts (usually) all values (zero and non-zero) by smoothing or diffusing the raw expression values 25 of cells with a similar expression profiles identified, for example, using neighbors in graph. The third approach first identifies 26 a latent space representation of the cells, either through low-rank matrix-based methods (capturing linear relationships) or 27 deep-learning methods (capturing non-linear relationships), and then reconstructs the observed expression matrix from the 28 low-rank or estimated latent spaces, which will no longer be sparse. For the deep-learning approaches, such as variational 29 autoencoders, both the estimated latent spaces and the "imputed" data (i.e. reconstructed expression matrix) can be used for 30 downstream analyses, but otherwise only the imputed data is typically provided for downstream analyses. 31 Due to their recent and concurrent development, evaluations and comparisons between scRNA-seq imputation methods 32 have been limited or restricted to a subset of imputation methods and downstream applications [13] [14] [15] [16] . Furthermore, imputation 33 methods can require varying types of raw or processed data as input, may rely on different methodological assumptions, 34 and may be appropriate for only certain scRNA-seq experimental protocols, such UMI-based [1] [2] [3] or full-length 4, 17 transcript 35 methods. Given these differences, the performance of these methods has been shown to vary in the evaluations to-date. For 36 example, one study found imputation methods can introduce false signals when identifying differentially expressed genes 37
In the first evaluation, we directly compared imputed scRNA-seq profiles from cell lines to a bulk RNA-seq profile 19 from the same cell lines (Figure 2A-D) . The test data include 10x Genomics UMI-based scRNA-seq data for 293T and 20 Jurkat cell lines (10x_293T_jurkat) and Fluidigm C1 plate-based scRNA-seq read count data for five ENCODE cell lines 21 (ENCODE_fluidigm_5cl). Using the rank-based Spearman correlation coefficient (SCC) 41 between the imputed scRNA-seq 22 profile and bulk profile, the majority of imputation methods (16 out of 18) were found to improve the correlation compared to 23 not imputing. Methods such as SAVER and SAVER-X (without pre-training) performed well with 10x Genomics UMI count 24 data, but the method's performance gain was not as pronounced with read count data from the plate-based Fluidigm platform, 25 as expected 20, 21 . Other methods such as scVI, DCA and MAGIC performed well in both settings. 26 In the second evaluation, we assessed an imputation method's ability to preserve the difference on the log scale between 27 two cell type profiles (i.e. two cell lines) by comparing the difference in two single-cell cell type profiles to the difference in 28 two bulk cell type profiles ( Figure 2E -H). Compared to Figure 2A -D, the majority though a smaller set of imputation methods 29 (13 out of 18) preserved the cell type difference better than no imputation. The imputation methods MAGIC, scVI, and DCA 30 resulted in the highest correlation using both UMI and non-UMI plate-based protocols, but SAVER and SAVER-X (without 31 pretraining) resulted in the highest correlation using UMI count data. Finally, in both Figures 2D and 2H, the performance of 32 some imputation methods was found to be affected by the number of cells in the dataset with a smaller number of observations 33 resulting in smaller correlation. 34 2.2 Impact of scRNA-seq imputation on identifying differentially expressed genes 35 Next, we evaluated the impact of imputation on the downstream analysis of identifying differentially expressed genes (DEGs). 36 We intentionally designed our evaluation to primarily rely on empirical analyses of real data in order to preserve gene-gene 37 correlations. In these empirical analyses, the ground truth was not completely known. Thus, our evaluation could not explicitly 38 calculate sensitivity and specificity as previously studies 14, 15 . However, we preferred empirical evaluation over simulation. 39 This is because some imputation methods model the expression levels for one gene based on the expression levels of other 40 genes, such as with SAVER and SAVER-X, simulation or spike-in studies in which ground truth is known but the gene-gene 41 correlation is disrupted would unfairly disfavor such methods. Also, modeling the complex gene-gene correlation in real data 42 via simulation and spike-in studies is difficult.
43
In the first analysis, we performed a differential expression enrichment analysis ( Figure 3A ). We treated genes identified as 44 differentially expressed in bulk RNA-seq data as a "gold standard" similar to previous studies 42 . We calculated the overlap of 45 DEGs between the bulk data and DEGs identified from scRNA-seq data between the same two cell types ( Figure S2A -G) using 46 two methods for single-cell differential expression, namely MAST 43 and Wilcoxon rank-sum test 44 (abbreviated as Wilcoxon) 47 and compared the performance ( Figure 3B -D). Different from the differential analysis in Figure 2E -H which only considers the 48 log-fold change (LFC) between cell types without taking into account cell variability, the analysis in Figure 3B -D additionally 49 considers cell variability and thus the uncertainty of LFC in order to rank genes, similar to what one would do in hypothesis 50 testing.
51
Using UMI-based 10x Genomics scRNA-seq data from five cell lines (sc_10x_5cl), we found that 10 and 8 out of the 18 52 methods outperformed no imputation when using MAST and Wilcoxon, respectively. Among them, kNN-smoothing, SAVER 53 A heatmap of the median correlation for each imputation method and each dataset across two experimental platforms (two datasets from the 10X Genomics platform and five datasets from the Fluidigm platform with the number of cells in each dataset in parentheses). The rows are sorted by first averaging the median correlations across datasets within each platform and then averaging across platforms. (E-H) Similar to (A-D) except, for any two cell types, the SCC is calculated comparing the difference in two bulk cell type profiles compared to two scRNA-seq cell type profiles. and SAVER-X (without pretraining) had the highest overlap of single-cell DEGs with bulk DEGs using MAST, but SAVER, Figure 2H ). Further investigation shows that the estimated gene-specific standard deviations from the MAGIC imputed 4 values were much smaller compared to the estimated standard deviations from other imputation methods ( Figure S3 ). In turn, 5 the estimated standard errors for the log-fold changes using MAGIC were small, leading to a wide test-statistic distribution and 6 a p-value distribution skewed toward small p-values ( Figure S4 ). These suggest that MAGIC could have inaccurately estimated 7 cell variability which reduced its gene ranking performance. 8 On the plate-based read count data from five cell lines from ENCODE (ENCODE_fluidigm_5cl), scVI performed best 9 using either MAST or Wilcoxon ( Figure S2D -E). However, only 7 and 1 out of the 18 methods increased the overlap of DEGs 10 compared to no imputation when using MAST and Wilcoxon, respectively.
11
We also compared methods using the UMI-based scRNA-seq bone marrow tissue data (HCA_10x_tissue) in 10x platform. to predict a cell type (e.g. B cell or not) using UMI-based sorted PBMC cell types. For some imputation methods, no imputed values were returned. They are denoted as "ImputationFail". (J-K) Using a UMI-based scRNA-seq dataset from cell lines (sc_10x_5cl), a heatmap showing the percentage of the overlap between bulk and single-cell DEGs identified using MAST stratified by genes with high (top 10%) or low (bottom 10%) log-fold changes. The color bar on the last column shows the mean overlap across all comparison for each method. If MAST failed to identify DEGs from the imputed profiles of any method in any dataset, we denoted it as "DifferentialFail". and data reconstruction based) that reported false positive DEGs. However, one factor associated with these false positives was In the third analysis, we asked if the imputed expression of known cell-type-specific marker genes can correctly predict 4 cell type. Using a UMI-based and FACS sorted peripheral blood mononuclear cell (PBMC) dataset 3 (PBMC_10x_tissue) and 5 5/28 entropy of cluster accuracy (ECA or H accuracy ), and entropy of cluster purity (ECP or H purity ). The last three were also used by is to its own cluster compared to other clusters). The last three metrics assess the similarity of predicted cluster labels to a 25 known ground truth, and they have been shown to have good correlation with each other 18 . The primary difference between the 26 last two is that ECA measures the diversity (or accuracy) of the true group label within each cluster assigned by the clustering 27 method, while ECP measures the diversity (or purity) of the predicted cluster labels within each of the true groups. We scaled 28 ARI to range between 0 and 1, and Silhouette index ranges between -1 and 1 -in both cases a higher score represents a 29 better performance, but ECA and ECP range between 0 and a number larger than one with a lower score representing a better 30 performance. 31 We applied each imputation method to seven datasets from CellBench 18 (Table S1, Section 5.1), a data compendium Figure 4A ). Overall, using latent spaces for the methods scVI (e.g. observations sampled from the posterior distribution using 39 scVI), scScope and SAUCIE was better than using their imputed expression values. We illustrate how individual cells cluster 40 along the first two principal components using an example dataset from CellBench (sc_celseq2_5cl_p1) with no imputation and 41 with imputation using MAGIC ( Figure 4B ). Using Louvain clustering yielded similar results ( Figure 4C , Figure S6 ) although 42 the top methods were slightly different (MAGIC, SAVER-X, SAVER, ALRA, bayNorm). 43 We further compared imputation methods using the scRNA-seq dataset of ten sorted PBMC cell types from 10x Genomics 3 44 (PBMC_10x_tissue). We applied both k-means clustering and Louvain clustering. For the imputation methods that successfully 45 returned imputed values, 6 methods including MAGIC, kNN-smoothing, SAVER-X, SAVER and SAUCIE_latent (the latent 46 space output by SAUCIE) outperformed no imputation ( Figure 4D ). In Figure 4E 51 We also evaluated the impact of imputation methods on inferring cells' pseudotemporal trajectories. In contrast to Section 52 2.3 which used data with distinct cell types to evaluate clustering, here we used datasets in which cells had a continuum of 53 transcriptomic profiles (e.g. cell differentiation) to assess if imputation methods could recover continuous biological processes. To compare imputation methods across metrics, the metrics were re-scaled to between 0 and 1 and the order of H acc and H pur were flipped to where a higher standardized score translates to better performance. Imputation methods (rows) are ranked by the average performance across all four metrics. Analogous to the section above, we applied methods to infer trajectories on the top principal components. We also included the 1 latent spaces directly provided by scVI, scScope and SAUCIE.
Impact of scRNA-seq imputation on inferring pseudotemporal trajectories
2 First, we applied imputation methods to six RNA mixture and cell mixture datasets from CellBench 18 followed by using 3 two trajectory analysis methods, Monocle 2 50 and TSCAN 49 . In these data, the true trajectories of cells were known. They were 4 used to evaluate the impact of imputation methods on the ability to infer trajectories. A similar evaluation using CellBench data and SAVER 20 ) with five trajectory inference methods. Here, we expanded their analysis to include 21 scRNA-seq imputation 7 methods. Our primary goal is to evaluate the imputation methods, but we do include two trajectory inference methods. The 8 performance metrics used in this analysis were (1) the Pearson correlation between cells' rank order along the inferred trajectory 9 and their rank order along the true trajectory, and (2) the proportion of cells for which the inferred branch overlapped (i.e., was 10 consistent) with the branch in the true trajectory. Both of these metrics have been previously described in and used to evaluate 11 inferred cell trajectories 18 .
12
Using the CellBench data, we found the imputation methods kNN-smoothing, SAVER, and ALRA led to both increased 13 correlation ( Figure 5A ) and overlap ( Figure 5B ) compared to no imputation using the TSCAN trajectory inference. Using 14 Monocle 2 trajectory inference, SAVER, kNN-smoothing, mcImpute, and the latent spaces from SAUCE (SAUCE_latent) 15 increased both the correlation ( Figure S8A ) and overlap ( Figure S8B ) compared to no imputation. This confirms the variability 16 in imputation methods' performance (depending on trajectory inference method), in particular for the overlap, that was 17 previously shown 18 ( Figure 5C-D) . Finally, analogous to results shown in Section 2.3, for imputation methods that return latent 18 spaces, using the latent spaces generally led to better performance than using the imputed expression values.
Figure 6.
Overall summary of results evaluating imputation methods for scRNA-seq data. Methods are ranked by performance metrics (scaled to apply the same color scale) averaged across four categories: evaluation of similarity between imputed single-cell profiles and bulk profiles in a homogeneous population of cells (imp_eval), differential expression enrichment analysis and null differential analysis (differential), unsupervised clustering and inferring trajectories for pseudotime analysis. A higher score represents a better performance. Results for using UMI or non-UMI (e.g. in this case Fluidigm) methods are also shown. 1 We have presented a systematic benchmark evaluation comprehensively comparing 18 scRNA-seq imputation methods. We 2 evaluated the performance of the imputation methods on their ability to recover similarity between imputed single-cell profiles 3 and bulk profiles in a homogeneous population of cells, and the impact of the imputation methods on three downstream analyses: 4 differential expression analysis, unsupervised clustering analysis, and pseudotime inference. We conclude by summarizing 5 our results in Figure 6 which ranked methods based on their average performance. Computational time, memory usage, and 6 scalability were not used to rank the methods. They were assessed separately using four datasets of 10 3 , 5 × 10 3 , 5 × 10 4 and 7 10 5 cells, respectively. Specifically, we used (1) computation time (in seconds), (2) memory (in maximum resident set size of 8 all tasks in job, i.e. MaxRSS, returned from sacct), and (3) scalability -regression coefficient in the linear model where the 9 computation time is fitted against the number of cells on the log 10 -scale. Figure S9 shows the comparison of time, memory and 10 scalability. Based on our evaluation, we provide a set of recommendations below for users and investigators to navigate the 11 current space of scRNA-seq imputation methods.
Discussion and Conclusions

12
Of the methods considered, MAGIC, kNN-smoothing and SAVER were found to outperform the other methods most 13 consistently ( Figure 6 ). However, the performance of methods varied across evaluation criteria, experimental protocols, datasets, 14 and downstream analyses. For example, scVI was one of the top performers in terms of the similarity between the imputed 15 single-cell and bulk expression profiles ( Figure 2 ), but it did not perform among the top in clustering and trajectory analysis 16 (Figures 4,5 ). SAVER-X performed consistently well using UMI-based method, but less well with non-UMI based methods 17 ( Figure 6 ). While MAGIC was one of the best performer overall ( Figure 6) , it performed worse than many other methods when 18 identifying differentially expressed genes in hypothesis testing type settings that take into account cell variability ( Figure 3) . 19 In addition, we found that while some imputation methods improve detecting differentially expressed genes or discovering 20 marker genes, they also can introduce false positive signals, often driven by imbalanced sizes of groups. The magnitude of effect 21 sizes (i.e. log-fold change) plays a role in the performance of the imputation methods: most imputation methods strengthen 22 9/28 large effect sizes compared to no imputation. However, if the original expression difference is small, then most imputation 1 methods smooth the small differential signal away and do not show clear advantage over no imputation ( Figure 3J ,K).
2
One important observation is that, while the majority of imputation methods outperformed no imputation in recovering bulk 3 expression (16/18 methods) and log fold changes of individual genes between cell types without considering cell variability 4 within each cell type (13/18 methods) ( Figure 2 ), much fewer methods performed better than no imputation for identifying 5 differentially expressed genes after considering cell variability (1-10/18 depending on the test scenario), clustering cells (5-6/21 6 methods) or inferring pseudotemporal trajectories (4-11/21 methods). Thus, the current imputation methods as a whole seem 7 to be most effective for providing a point estimate of the activity of individual genes, and they become less effective when 8 coupled with various downstream analysis tasks. For differential expression analysis, the decreased effectiveness is likely due 9 to inaccurate cell variance characterization after imputation. For clustering and trajectory analysis, the reduced effectiveness is 10 likely because these two analyses attempt to analyze cell-to-cell relationship rather than individual genes. Cell clustering and 11 trajectory analysis are usually conducted by embedding the high-dimensional expression vector of each cell into a relatively 12 low-dimensional space. Each dimension in the low-dimensional space combines information from many genes, which increases 13 signal-to-noise ratio by diluting technical noise such as observed zeros due to technical variation, even without imputation. An open question to be investigated in the future is whether the improvement on the various downstream analysis tasks by 18 imputation has already reached its upper limit, and if not, how to design new imputation methods to further improve the analysis 19 of cell-to-cell relationship or differential expression that takes into account cell variability.
20
In terms of computation, MAGIC, DCA and DeepImpute are among the most efficient methods. kNN-smoothing, ALRA, 21 bayNorm, scImpute, SAUCIE, scScope exhibit high scalability. SAVER-X, SAVER and SAVER-X are intermediary while the 22 remaining methods do not scale well for large datasets ( Figure S9 ).
23
Our comparison is subject to several limitations. Firstly, the imputation methods were mostly compared with default 24 parameters which may not achieve optimal performance across all datasets. Our work could be further improved with the use of 25 methods such as molecular cross-validation (MCV) 52 . Another limitation is we used 72 hours as the time limit for convergence 26 for imputation methods, which does not guarantee algorithmic convergence for some methods. In our evaluation of imputation 27 methods on inferring pseudotime with trajectory analysis methods, the cell types of the tissue HCA_10x_tissue cells were 28 computationally annotated. However, our benchmark evaluation will benefit many current researches using scRNA-seq data 29 as it highlights the advantages and disadvantages of existing imputation methods, and that the performance of an imputation 30 method depends on many external factors, such as experimental protocols and analyses usage. It also provides an evaluation 31 standard for new imputation methods. 
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Methods
39
All methods were evaluated with default parameters, with the exception of the deep-learning-based methods for which the 40 maximum epoch time was set as 400. We used 72 hours as the time limit for convergence for the imputation methods. This did 41 not guarantee algorithmic convergence for some methods. For a description of the data, see Section 5.1 and Table S1 . For 42 complete details on the methods used, the input, the output, pre-processing steps, the programming language used, version 43 number and link to software, see Table S2 . • All UMI-based data from five cell lines (HCC827, H1975, H2228, H838, A549) in the CellBench 18 benchmarking 14 dataset (except for cellmix5, a population control) using the CEL-seq2 protocol (sc_celseq2, sc_celseq2_5cl_p1, 15 sc_celseq2_5cl_p2, sc_celseq2_5cl_p3, cellmix1, cellmix2, cellmix3, cellmix4, RNAmix_celseq2), Drop-seq 16 Dolomite protocol (sc_dropseq), the Sort-seq protocol (RNAmix_sortseq), and 10x Chromium Genomics protocol 17 (sc_10x, sc_10x_5cl)). For a description of the experimental design, GEO accession numbers, protocol parameters, 18 see the sc_mixology GitHub repo and Table S1 . 33 We applied the same quality control (QC) criterion across all single-cell datasets. Cells with at least 500 detected genes were 34 retained. ERCC spike-ins were removed. Genes expressed in at least 10% of cells in cell line data and 1% of cells in tissue 35 samples were retained. Mitochondrial genes were removed. We applied these cell-and gene-filtering steps to all imputation 36 methods and skipped each method's own gene-and cell-filtering (if applicable) to keep the dimension of the imputed values 37 (output) the same across imputation methods. Single-cell profiles from UMI-based Jurkat and HEK293T cell lines were 38 combined into one UMI count matrix (10x_293t_jurkat) which was used as input to each imputation method. A similar 39 procedure was applied to the five Fluidigm-based ENCODE cell lines (ENCODE_fluidigm_5cl). Data were normalized by 40 the pooling normalization method 37 implemented in the scran 38 R/Bioconductor 39, 40 package and log 2-transformed if any 41 imputation method requires normalized counts or log-transformed normalized counts as input. We added post-processing steps 42 for methods if required. For example, if a method did not normalize nor apply a log-transformation before or during imputation, 43 we applied scran normalization and log 2-transformation to the output. If a method included normalization but does not 44 log-transform the data during imputation, we applied log 2-transformation to the output. performance metric. 48 12/28 5.5.2 Null differential analysis 1 For each dataset in this analysis, we started with a homogeneous population of cells where we expect no DEGs after correction 2 for multiple testing. We used the the 293T cells from the 10x_293t_jurkat dataset (N=2885 cells), the GM12878 cell line from 3 the ENCODE_fluidigm_5cl dataset (N=96 cells), and the cell type with the largest number of cells from the HCA_10x_tissue 4 (N=193 monocytes). For each dataset, we randomly sampled cells into two groups with group size ranging from N = 10 to 1000 5 cells per group, imputed the expression values of these two groups together and identified DEGs using MAST 43 and Wilcoxon 6 rank-sum test 44 . We filtered for FDR smaller than α = 0.05. Using the sorted peripheral blood mononuclear cells (PBMCs) 3 (PBMC_10x_tissue dataset), we assessed the performance of an 9 imputation method on recovering the expression level of known PBMC marker genes. The cell type-specific marker genes used 10 in this analysis were the following: CD19 for B cells; CD14 for monocytes; CD34 for CD34+ cells; CD3D for CD4 T helper 11
Single-cell RNA-seq data
cells, cytotoxic T cells, memory T cells, naive cytotoxic T cells, naive T cells, regulatory T cells; CD4 for CD4 T_helper cells, 12 memory T cells, naive T cells, regulatory T cells; CD8A for cytotoxic T cells and naive cytotoxic T cells.
We evaluated the 13 performance of predicting a cell type (e.g. B cell) based on the imputed expression of a marker gene (e.g. CD19). For each cell 14 type and marker gene pair, we calculated the area under the receiver operating characteristic (ROC) curve (AUROC) using the 15 performance function in the ROCR R package where the expression of the marker gene is the predictor and the true cell 16 type is the label. Specifically, the cells were first sorted in a descending order according to the imputed values of the marker 17 gene (e.g. CD19). Consider the cell type A. Assume there were K cells in total and b of them were in cell type A. Assume 18 in the top N cells, a of them were in cell type A; in the remaining K − N cells, c of them were not in cell type A. Sensitivity 19 was calculated as a/b and specificity was calculated as c/(K − b). The ROC curve was obtained by plotting sensitivity against 20 1-specificity for different Ns ( N = 1, 2 , ..., K). 22 We used two sets of datasets for this analysis. The first set is CellBench 18 data, which consists of 7 datasets. Three of these 23 datasets contained three cell lines (datasets: sc_10x, sc_dropseq, sc_celseq2) and four datasets contained five cell lines (datasets: 24 sc_10x_5cl, sc_celseq2_5cl_p1, sc_celseq2_5cl_p2, sc_celseq2_5cl_p3). The second set of data contains sorted PBMCs 3 25 (N=59620) with 10 cell types.
21
Evaluation of imputation on unsupervised clustering
26
Clustering was performed using both k-means 45 and Louvain clustering 46 where the number of clusters was set to be the 27 number of known cell types known in each dataset. In k-means we directly set k to be the number of known cell types, while 28 in Louvain clustering this is achieved by increasing the number of nearest neighbors iteratively until the desired number of 29 clusters is obtained. Louvain clustering was performed by performing feature selection using highly variable genes (HVGs), 30 applying PCA by prcomp(), and then building a shared k-nearest-neighbors (kNN) graph 46 based on the Euclidean distances 31 of the top 10 PCs. An edge was drawn between all pairs of cells sharing at least one neighbor, weighted by the characteristics 32 of the shared nearest neighbors. For this last step, we used the buildSNNGraph function in the scran 38 R/Bioconductor 33 package with the top 10 PCs as input, d = NA and other parameters as default. Clusters were identified by a multi-level 34 modularity optimization algorithm for finding community structure 59 using cluster_louvain in igraph R package. 35 K-means clustering was performed using the top 10 PCs.
36
To evaluate the performance of each method, we used four metrics: 
where M is the total number of predicted clusters from the clustering algorithm, N is the number of ground-truth clusters, 38 and N i is the number of ground-truth clusters in the i th predicted cluster. x j are cells in the j th ground-truth cluster, and 39 p i (x j ) are the proportions of cells in the j th ground-truth cluster relative to the total number of cells in the i th predicted 40 cluster. A smaller value of H accuracy is better as it means the cells in a predicted cluster are homogeneous and from the 41 same group 18 . However, H accuracy can lead to over-clustering, with an extreme case being treating each cell as a cluster 42 (or H accuracy = 0). 
where N is the total number of ground-truth clusters, M i is the number of predicted clusters in the i th true cluster. x j are 1 cells in the j th predicted cluster, and p i (x j ) are the proportions of cells in the j th predicted cluster relative to the total 2 number of cells in the i th ground-truth cluster. A smaller value of H purity is better as it means the cells in the ground-truth 3 groups are homogeneous with the same predicted cluster labels 18 . However H purity can lead to under-clustering, with an 4 extreme case being assigning all cells into one predicted cluster so that each of the ground-truth groups has the same 5 predicted cluster label (H purity = 0). 6 3. Adjusted Rand index 60 (ARI). We used the adjustedRandIndex function in mclust package 61 . The minimum 7 ARI of each dataset was obtained by permuting cells' ground-truth cell type labels 10 4 times, recomputing ARI, and 8 averaging the 10 4 ARIs from random permutations. The maximum has been theoretically proved as 1. We subtract the 9 ARI by the empirical minimum and divided by the distance between the empirical minimum and theoretical maximum. where i is a cell, C i is the set of cells in the same cluster as i, |C i | is its cardinality (i.e., number of cells in a cluster), coefficient was greater than 0.6. If no cell type label was assigned to a cell in this way, the cell's cell type was labeled as 24 unknown. Next, k-means clustering was performed on the cells. For each cluster, if at least 70% of cells were inferred as cell 25 type A, then all cells in the cluster were relabeled as cell type A. If a cluster cannot be labeled in this way, then all cells in the 26 cluster were labeled as unknown cell type. The largest cluster obtained in this procedure contained N=197 cells inferred as 27 monocytes. They were used for the null differential analysis described before. We used the (1) CellBench 18 RNA mixture (RNAmix_celseq2, RNAmix_sortseq) and cell mixture (cellmix1, cellmix2, cellmix3, 31 cellmix4) datasets from three cell lines (H2228, H1975, HCC827) generated by CEL-seq2 and SORT-seq protocols 18 and (2) 32 bone marrow cells from the HCA_10x_tissue 11 . Monocle 2 50 and TSCAN 49 were used to construct trajectories on the imputed 33 expression values. Monocle 2 uses a DDR-Tree (Discriminative DRTree) 63 for dimensionality reduction and tree construction.
34
For TSCAN, we calculated the top principal components (PCs) with the prcomp function in the stats R package. We then 35 run k-means clustering (using the kmeans function in the stats R package) on the top PCs (obtained by TSCAN using 36 elbow method) to obtain predicted cluster labels for each cell. Then, we used the predicted cluster labels and top PCs as input 37 to TSCAN. The number of clusters was chosen to be the smallest one that allowed two branches in the spanning tree to be 38 consistent with the underlying true tree structure.
39
To identify the root cells or root state when inferring trajectories with TSCAN and Monocle 2 using CellBench data, the 40 cluster with the most H2228 cells was selected. For HCA_10x_tissue data, each cell was assigned a differentiation level, as We created four datasets for this analysis. Using the 10x_293t_jurkat dataset, we created two smaller datasets by randomly 11 sampling N=1000 and N=5000 cells (1k_cell, 5k_cell, respectively). Using the HCA_10x_tissue dataset, we created two larger 12 datasets by randomly sampling N=50,000 and N=100,000 cells (50k_cell, 100k_cell, respectively). By running the imputation 13 methods on all datasets, we assessed the computational time (in minutes), memory usage (in maximum resident set size of 14 all tasks in job (MaxRSS or maximum resident set size of all tasks in a job) in gigabytes returned from the Slurm command 15 sacct), and scalability with respect to cell number. For each method, a linear model was fit using the lm function from the 16 stats R package where the computation time was the response and the number of cells on the log 10 -scale was the predictor 17 ( Figure S9 ). The coefficient of the cell number represents the scalability of the method. For methods that failed to produce 18 results, the running time was set to be the maximum time (72 hours) plus 1 minute, and the memory was set to be the maximum 19 memory. The time and memory were linearly scaled to [0, 1]. The average scaled time and memory across all datasets were 20 used as the final score as shown in Fig.6 . 21 5.10 Overall performance score 22 All the assessment measures were mapped to [0, 1] by subtracting the theoretical minimum and then dividing by the difference 23 of the theoretical maximum and minimum. Empirical extrema were used when theoretical ones did not exist. Ten thousand 24 permutations was applied to obtain the empirical minimum of ARI for each dataset. H accuracy and H purity were further subtracted 25 by 1 for the convenience of applying "the higher the score, the better the performance" criterion. Efficiency measures (time, 26 memory, scalability) were scaled with the extrema of all methods' performance.
27
Evaluation of imputed values through the similarity to bulk samples, differential analysis, clustering and pseudotime 28 inference were considered as four main assessment aspects. In each aspect, the scores across datasets were first averaged, and 29 next the mean from different analysis tools (MAST and Wilcoxon; k-means and Louvain clustering; Monocle 2 and TSCAN) 30 were averaged, then the mean of multiple assessment statistics (e.g. overlap and correlation in assessing pseudotime inference) 31 was used as the evaluation score. The mean scores of all four assessment aspects was finally used to rank all methods. 32 5.11 Data and code availability 33 The data used in this analysis are described in Section 5.1 and Table S1 with all links or GEO accession numbers. The 34 imputation methods are described in Table S2 . All code to reproduce the presented analyses are available at https: 35 //github.com/Winnie09/imputationBenchmark. The R package ggplot2 64 for data visualization was used. Table S1 . Summary of all datasets used in each evaluation of this benchmark. The table includes the names, protocols, source (GEO accession numbers or links to download) and cell details of each dataset. Table S2 . Summary of all scRNA-seq imputation methods used in each evaluation of this benchmark. The table includes the name of the method, input, output, pre-processing steps for each method that we applied, the programming language, assumptions about the me thod, the download date, software version number, and link to software package. Table S3 . Values of all three efficient measures in time, memory and scalability using all four datasets. The table include the computation time and memory of four datasets with 10 3 , 5 × 10 3 , 5 × 10 4 , 10 5 cells for all imputation methods. Scalability is the coefficient of the cell number of each dataset in the linear model where the number of cells on the log 10 -scale is fitted against the computation time.
19/28
Figure S1. Dimension reduction results after applying Principal Components Analysis (PCA) from either no imputation (no_imp) or the 18 imputation methods using the null simulations data (Section 5.3), except the difference between this figure and Figure 1A is this figure includes the latent spaces directly found by scScope (scScope_latent), scVI (scVI_latent) and SAUCIE (SAUCIE_latent) (not Principal Components -PCs). All other methods are showing observations along the first two PCs. The color represents the simulated library size (defined as the total sum of counts across all relevant features) for each cell. 20/28 Figure S2 . Impact of imputation methods on differential expression analysis. (A) Schematic of evaluating differentially expressed genes (DEGs) using the overlap between bulk RNA-seq and scRNA-seq -also shown in Figure 3A . Using the pairs of cell lines in the sc_10x_5cl dataset, ENCODE_fluidigm_5cl dataset, and pairs of cell types in the bone marrow tissue from the HCA_10x_tissue dataset, we show heatmaps of proportion of overlap between bulk and single-cell DEGs identified using (B, D, F) MAST 43 and (C, E, G) Wilcoxon-rank-sum test 44 (abbreviated as Wilcoxon) for differential expression, respectively. (H) Schematic of a null differential expression analysis by randomly partitioning cells from the same cell type into two groupsalso shown in Figure 3E . Using the 293T cells from the 10x_293t_jurkat dataset, the GM12878 cells from the ENCODE_fluidigm_5cl dataset, and bone marrow cells from the HCA_10x_tissue dataset, the number of false positive DEGs identified using (I, K, M) MAST and (J, L, N) Wilcoxon, respectively. The x-axis in Figures (I-N) describe the number of cells in each group (e.g. 10 sampled cells in group 1 and 10 sampled cells in group 2) when applying a method to identify differentially expressed genes. White areas with black outline indicate that the imputation methods did not return output after 72 hours and areas with grey outline indicate that either MAST or Wilcoxon failed to return results. Figure S5 . Impact of imputation methods on k-means clustering analysis using seven datasets from CellBench single cells. Heatmaps of the individual performance metrics (A) entropy of cluster accuracy (H acc ), (B) entropy of cluster purity (H pur ), (C) adjusted Rand index (ARI), and (D) the median of Silhouette and median Silhouette index of each imputation method for each of the seven datasets in CellBench 18 . The white boxes with black lines represent cases in which no output was returned from the imputation method after 72 hours. The white boxes with gray lines represent cases in which the clustering algorithm failed to cluster the cells using the principal components, for instance "more cluster centers than distinct data points" because many cells with imputed profiles are identical. Figure S6 . Impact of imputation methods on Louvain clustering analysis using seven datasets from CellBench 18 . (A) Heatmap of four performance metrics -entropy of cluster accuracy (H acc ), entropy of cluster purity (H pur ), adjusted Rand index (ARI), and median Silhouette index -averaged across seven datasets. To compare imputation methods across metrics, the metrics were re-scaled to be between 0 and 1 and the order of H acc and H pur were flipped to where a higher standardized score translates to better performance. Imputation methods (rows) are ranked by the average across all four metrics. (B) Dimension reduction results after applying PCA to the sc_celseq2_5cl_p1 data with no imputation (left) and with imputation using MAGIC (right). The colors are the true group labels. (C) Overall score (or average of the four performance metrics) for Louvain clustering (x-axis) and k-means clustering (y-axis). (D-G) Heatmaps of the individual performance metrics (D) H acc , (E) H pur , (F) ARI and (G) the median of Silhouette of each imputation method for each CellBench dataset. The white boxes with black lines represent cases in which no output was returned from the imputation method after 72 hours. Figure S7 . Impact of imputation methods on Louvain clustering analysis using ten sorted peripheral blood mononuclear cell (PBMC) cell types from 10x Genomics. (A) Heatmap of four performance metrics -entropy of cluster accuracy (H acc ), entropy of cluster purity (H pur ), adjusted Rand index (ARI), and median Silhouette index -on data from 10x Genomics 3 . To compare imputation methods across metrics, the metrics were re-scaled to be between 0 and 1 and the order of H acc and H pur were flipped to where a higher standardized score translates to better performance. Imputation methods (rows) are ranked by the average across all four metrics. (B) Dimension reduction results using UMAP components 48 with no imputation (left) and with imputation using MAGIC (right). The colors are the true group labels. (C) Overall score (or average of the four performance metrics) for Louvain clustering (x-axis) and k-means clustering (y-axis). White areas with black outline in (D) indicate that the imputation methods did not return output after 72 hours. Figure S8 . Impact of imputation methods on inferred trajectories for pseudotime analysis using Monocle 2 with the RNA mixture and cell mixture datasets from CellBench 18 . (A) Heatmap showing the Pearson correlation coefficients (PCC), denoted as correlation, between the inferred trajectory and the rank order of the cells where we know the true trajectory (or ordering) of the cells. (B) Heatmap of the proportion of cells on the inferred trajectories that correctly overlap with the cells on the branch where we know the true trajectory of the cells. Figure S9 . Values of time, scalability and memory of each imputation method on each dataset before scaling. (A) Computation time (in minutes) for each method to finish imputing four datasets of 10 3 , 5 × 10 3 , 5 × 10 4 and 10 5 cells, respectively. For some imputation methods, no results are shown because no imputed values were returned within 72 hours. Scalability (marked in the parentheses after each methods's name) is defined by fitting a linear model with the number of cells on the log 10 -scaled on the x-axis and the computation time on the y-axis and using the coefficient as the metric for scalability. (B) Memory usage ( in maximum resident set size of all tasks in job (MaxRSS) in gigabyte, i.e. GB, returned from the Slurm command sacct) for each method to finish imputating the four datasets mentioned above.
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